PURPOSE: The financial toxicity of anticancer drugs is well-documented, but little is known
about the costs of drugs used to manage cancer-associated symptoms. METHODS: We …

Importance There are no known effective treatments for painful chemotherapy-induced
peripheral neuropathy. Objective To determine the effect of duloxetine, 60 mg daily, on …

CRA9013 Background: CALGB 170601 was a randomized, placebo-controlled phase III trial
to determine whether duloxetine reduces painful chemotherapy-induced peripheral …

Background: Cancer patients often experience symptoms such as anorexia, anxiety and
insomnia, which can impact their quality of life. Randomized placebo-controlled trials …

PURPOSE Anorexia occurs in 30%-80% of patients with advanced malignancies, which
may be worsened with chemotherapy. This trial assessed the efficacy of olanzapine in …

Objective. Chemotherapy‐associated peripheral neuropathy (CAPN) is a painful side‐effect
of chemotherapy. This study assesses healthcare and workloss costs of CAPN patients with …

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common and
debilitating complications of cancer treatment. Due to a lack of effective management …

Purpose Chemotherapy-induced peripheral neuropathy (CIPN) is a disabling complication
of many chemotherapies. We investigated the feasibility of using health plan claims and …

The issue of drug price, particularly in the area of specialty pharmaceuticals, has emerged
as a bipartisan concern with both members of Congress and the Administration. Specialty …

Opinion statement Chemotherapy-induced peripheral neuropathy (CIPN) is a common
toxicity associated with multiple chemotherapeutic agents. CIPN may have a detrimental …